Brief: Longboard Pharmaceuticals Says Lundbeck To Acquire Co In Strategic Deal
14/10/2024 11:53
Oct 14 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* LUNDBECK TO ACQUIRE LONGBOARD PHARMACEUTICALS IN A
STRATEGIC
DEAL, SIGNIFICANTLY ENHANCING ITS NEUROSCIENCE PIPELINE
* LONGBOARD PHARMACEUTICALS INC: TOTAL TRANSACTION VALUE OF
APPROXIMATELY USD 2.6 BILLION
Source text for Eikon: ID:nBw53QXtxa
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions